2021
Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma
Spees LP, Wheeler SB, Jackson BE, Baggett CD, Wilson LE, Greiner MA, Kaye DR, Zhang T, George D, Scales CD, Pritchard JE, Leapman M, Gross CP, Dinan MA. Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Cancer Medicine 2021, 10: 6653-6665. PMID: 34480518, PMCID: PMC8495289, DOI: 10.1002/cam4.4201.Peer-Reviewed Original ResearchConceptsMetastatic renal cell carcinomaPatient-level factorsRenal cell carcinomaCell carcinomaRisk ratioState cancer registry dataPatient-level predictorsPatient-level characteristicsCancer registry dataProvider Enumeration SystemMRCC diagnosisMedical oncologyInsurance typeMedicare patientsRegistry dataFemale providersPatientsMedian proportionPoisson regressionCare issuesPrivate insuranceMale providersAdherenceCarcinomaAnticancer agents
2020
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm
Smith LB, Desai NR, Dowd B, Everhart A, Herrin J, Higuera L, Jeffery MM, Jena AB, Ross JS, Shah ND, Karaca-Mandic P. Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm. International Journal Of Health Economics And Management 2020, 20: 299-317. PMID: 32350680, PMCID: PMC7725279, DOI: 10.1007/s10754-020-09282-2.Peer-Reviewed Original ResearchConceptsPermanent atrial fibrillationType 2 diabetesAtrial fibrillationPermanent atrial fibrillation patientsProvider-level factorsAtrial fibrillation patientsEffective new therapiesPrimary care providersUse of medicationsProvider-level characteristicsUtilization of treatmentHigh-quality health careDronedarone useInterrupted time-series regression modelsFibrillation patientsMedication useDiabetes patientsProvider characteristicsCare providersMedicare feeNew therapiesService claimsFemale providersPatientsMedications
2003
Provider Characteristics and Mammography Recommendation among Women in Their 40s and 50s
Dominick KL, Skinner CS, Bastian LA, Bosworth HB, Strigo TS, Rimer BK. Provider Characteristics and Mammography Recommendation among Women in Their 40s and 50s. Journal Of Women's Health 2003, 12: 61-71. PMID: 12639370, DOI: 10.1089/154099903321154158.Peer-Reviewed Original ResearchConceptsMammography recommendationsProvider characteristicsRegular providerMammography useProvider genderMultivariate logistic regression modelFourth of womenPrimary care physiciansWomen age 40Healthcare provider recommendationObstetrician/gynecologistsWomen's mammography useLarger intervention studyLogistic regression modelsCare physiciansProvider recommendationMammography guidelinesAge 40Female providersIntervention studiesHealthcare providersMale providersWomenBaselineHealth insurance
1998
Differences in Providers' Beliefs about Benefits and Risks of Hormone Replacement Therapy in Managed Care
Exline J, Siegler I, Bastian L. Differences in Providers' Beliefs about Benefits and Risks of Hormone Replacement Therapy in Managed Care. Journal Of Women's Health 1998, 7: 879-884. PMID: 9785314, DOI: 10.1089/jwh.1998.7.879.Peer-Reviewed Original ResearchConceptsHormone replacement therapyRisks of HRTReplacement therapyBreast cancerFamily physiciansBenefits of HRTProviders' beliefsProvider-patient discussionsGender of physiciansHealth maintenance organizationCross-sectional surveyThromboembolic eventsHeart diseasePhysicians' beliefsPhysician genderCare settingsFemale providersAlzheimer's diseasePhysician assistantsFemale physiciansMaintenance organizationPhysiciansDiseaseManaged CareRisk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply